Emerging Issues in Neurology
Quality Resources
Emerging Issues in Neurology documents are intended to provide guidance from a panel of expert authors about new or emerging issues that have immediate implications for the care of patients with neurologic disorders. These documents are different from clinical practice guidelines and Evidence in Focus products as outlined in the table below.
Current Emerging Issues in Neurology Articles
- Implications of Large Language Models for Quality and Efficiency of Neurologic Care (2024)
- Antiamyloid Monoclonal Antibody Therapy for Alzheimer Disease (2023)
- Neurologic Care of Forcibly Displaced Persons (2023)
- COVID-19 and Vaccination in the Setting of Neurologic Disease (2021)
Policy and Procedure Manual
The AAN Quality Committee launched the Emerging Issues in Neurology document type in 2022 to meet clinician needs. Learn more about how these documents are developed.
Read the Policy and Procedure Manual
Emerging Issues in Neurology Topic Nomination
To submit an idea for an Emerging Issues in Neurology document, fill out the form below. Before you submit a topic, please review the information on this page to ensure your topic is appropriate for this type of document. All topics are reviewed by the Quality Committee on a rolling basis. If you would like to submit a topic for a clinical practice guideline or an Evidence in Focus document, you can do so here. Reach out to quality@aan.com with questions.
Guideline | Evidence in Focus | Emerging Issues in Neurology | |
Average Time to Publication | 4–7 years | 10–20 months | 6–12 months |
Developed by AAN Quality Committee | X | ||
Developed by AAN Guidelines Subcommittee | X | X | |
Patient or Caregiver Representation |
X | X | Possible but not required |
Project Development Plan with PICO Questions | X | Limited to 1 PICO | |
Literature Review | X | X | |
Modified GRADE Evidence Synthesis | X | When possible | |
Public Comment | X | ||
Evidence-based Recommendations | X | ||
FDA Labeling Discussion | X | ||
Clinical Context | X | X | X |
Questions?
Contact the Quality Team with questions or to request more information.